Quantum BioPharma Ltd. Diluted Earnings Loss Per Share From Continuing Operations
Quantum BioPharma Ltd. (QNTM) reported Diluted Earnings Loss Per Share From Continuing Operations of -$8.20 per share for the 12-month period ending 2025-12-31, per its 20-F filed 2026-03-26.
Financial Statements › Income Statement › Earnings Per Share
ifrs-full:DilutedEarningsLossPerShareFromContinuingOperations · last filed 2026-03-26
- Quantum BioPharma Ltd. diluted earnings loss per share from continuing operations for the quarter ending 2025-09-30 was -$1.25.
- Quantum BioPharma Ltd. diluted earnings loss per share from continuing operations for the quarter ending 2025-06-30 was -$3.23.
- Quantum BioPharma Ltd. diluted earnings loss per share from continuing operations for the quarter ending 2025-03-31 was -$3.53.
- Quantum BioPharma Ltd. diluted earnings loss per share from continuing operations for the quarter ending 2024-09-30 was -$4.37.
| Period end | Diluted Earnings Loss Per Share From Continuing Operations 3 month | Diluted Earnings Loss Per Share From Continuing Operations 6 month | Diluted Earnings Loss Per Share From Continuing Operations 9 month | Diluted Earnings Loss Per Share From Continuing Operations 12 month |
|---|---|---|---|---|
| 2025-12-31 | -$8.20 20-F · filed 2026-03-26 | |||
| 2025-09-30 | -$1.25 6-K · filed 2025-11-06 | -$7.49 6-K · filed 2025-11-06 | ||
| 2025-06-30 | -$3.23 6-K · filed 2025-08-07 | -$6.73 6-K · filed 2025-08-07 | ||
| 2025-03-31 | -$3.53 6-K/A · filed 2025-06-16 | |||
| 2024-12-31 | -$13.12 20-F · filed 2026-03-26 | |||
| 2024-09-30 | -$4.37 6-K · filed 2025-11-06 | -$11.06 6-K · filed 2025-11-06 | ||
| 2024-06-30 | -$0.08 6-K · filed 2025-08-07 | -$0.13 6-K · filed 2025-08-07 | ||
| 2024-03-31 | -$3.43 6-K/A · filed 2025-06-16 | |||
| 2023-12-31 | -$29.93 20-F · filed 2026-03-26 | |||
| 2022-12-31 | -$0.69 20-F · filed 2023-03-31 | |||
| 2021-12-31 | -$0.97 20-F · filed 2023-03-31 | |||
| 2020-12-31 | -$2.36 20-F · filed 2023-03-31 |